18-Methylaminocoronaridine
Chemical compound / From Wikipedia, the free encyclopedia
(−)-18-Methylaminocoronaridine (18-MAC) is a second generation synthetic derivative of ibogaine developed by the research team led by the pharmacologist Stanley D. Glick from the Albany Medical College and the chemist Martin E. Kuehne from the University of Vermont.[1][2]
Quick Facts Identifiers, PubChem CID ...
Identifiers | |
---|---|
PubChem CID | |
ChemSpider |
|
Chemical and physical data | |
Formula | C22H29N3O2 |
Molar mass | 367.493 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Close